For the new study, researchers tested whether a low maintenance dose of 30 milligrams would work as well as a 300-milligram ...

What if instead of temporarily relieving your allergies with medication, you could train your immune system to stop overreacting to your allergens altogether? That’s the idea behind allergy ...

A systematic review of randomized clinical trials suggests that both sublingual and subcutaneous allergen immunotherapy are effective options for managing allergic rhinitis ...

A clinical trial comparing low- and standard-dose peanut oral immunotherapy found both improved peanut tolerance, but lower ...

Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection against ...

Researchers have developed an alternative way of desensitizing very young peanut-allergic children to the food. Under-the-tongue immunotherapy was found to be safer and easier to administer than the ...

Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study OverviewRegeneron Pharmaceuticals has launched a new ...

The integration of Artificial Intelligence into healthcare has opened doors to unprecedented advancements, particularly in the realm of allergy immunotherapy. This evolving landscape of medical ...

Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological ...

Shares in the company rose more than 35% on the strength of the data, which could put DBV on track to bring the immunotherapy to market in the US as the first alternative to Stallergenes Greer's ...

Please provide your email address to receive an email when new articles are posted on . 76.7% of non-Hispanic Black respondents had never heard of oral immunotherapy before the survey. 51% of ...